Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients

The presence of comutations (co-mut+) in DNA damage response and repair (DDR) pathways was associated with improved survival for immune checkpoint inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC). However, it remains unknown whether co-mut+ status could be a predictive biomarker for imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Anning, Nie, Wei, Zhou, Yan, Li, Changhui, Gu, Kai, Zhang, Ding, Chen, Shiqing, Wen, Fengcai, Zhong, Hua, Han, Baohui, Zhang, Xueyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499805/
https://www.ncbi.nlm.nih.gov/pubmed/34630387
http://dx.doi.org/10.3389/fimmu.2021.708558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499805/
https://www.ncbi.nlm.nih.gov/pubmed/34630387
http://dx.doi.org/10.3389/fimmu.2021.708558

Ejemplares similares